Vaxcell-Bio Therapeutics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-10,624	-10,274	-6,825	-4,763	-3,984
Depreciation & Amortization	1,466	399.68	311.34	257.25	185.31
Loss (Gain) From Sale of Assets	32.73	-	0.05	0.25	-
Loss (Gain) From Sale of Investments	182.7	126.84	-	-	-
Stock-Based Compensation	208.74	181.65	38.22	46.92	132.03
Other Operating Activities	-230.89	376.03	713.6	350.44	535.3
Change in Accounts Receivable	-821.7	-0.08	-	-	-
Change in Inventory	-87.47	-96.74	-	-	-
Change in Accounts Payable	226.21	-	-	-	-
Change in Other Net Operating Assets	-1,051	-136.3	-282.79	-553.84	-171.64
Operating Cash Flow	-10,699	-9,423	-6,045	-4,662	-3,303
Capital Expenditures	-2,125	-165.8	-167.38	-2,124	-26.91
Sale of Property, Plant & Equipment	127.27	-	-	-	-
Cash Acquisitions	-4,828	-	-	-	-
Sale (Purchase) of Intangibles	-1,941	-32.7	-122.83	-104.05	-5.02
Investment in Securities	19,441	-50,998	4,998	-1,000	-20,000
Other Investing Activities	-352.34	-590.65	-373.99	-9	-17.41
Investing Cash Flow	10,322	-51,787	4,333	-3,237	-20,049
Long-Term Debt Repaid	-849.19	-216.66	-207.85	-205.83	-185.75
Net Debt Issued (Repaid)	-849.19	-216.66	-207.85	-205.83	-185.75
Issuance of Common Stock	-	71,790	-	597.38	29,366
Repurchase of Common Stock	-	-532.7	-	-	-
Other Financing Activities	0.34	-1,174	-	-86.8	-
Financing Cash Flow	-848.85	69,866	-207.85	304.75	29,180
Miscellaneous Cash Flow Adjustments	-0	-	-	-	0
Net Cash Flow	-1,225	8,657	-1,919	-7,594	5,828
Free Cash Flow	-12,824	-9,589	-6,212	-6,785	-3,330
Free Cash Flow Margin	-675.31%	-69872.25%	-	-	-
Free Cash Flow Per Share	-558.88	-489.05	-408.07	-448.78	-488.95
Cash Income Tax Paid	141.28	52.84	59.86	5.16	-8.26
Levered Free Cash Flow	-12,669	-7,065	-4,650	-6,434	-2,291
Unlevered Free Cash Flow	-12,529	-7,037	-4,640	-6,417	-2,270

Source: S&P Global Market Intelligence. Standard template. Financial Sources.